MYC and diffuse large B-cell lymphoma: In line with a destabilized G1/S border as a common denominator for CHK1 inhibitor sensitivity, other groups have reported that MYC-driven diffuse large B cell lymphoma and CCND1-driven mantle cell lymphoma display a marked sensitivity against the CHK1 inhibitor PF-47773650,51.